LONG-TERM CLINICAL OUTCOMES IN PEOPLE WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION (HFPEF) TREATED WITH STANDARD CARE

被引：0
|
作者：
Sun, L. [1 ]
Dayer, V [1 ]
Hansen, R. N. [1 ]
Du, Y. [2 ]
Williamson, T. [2 ]
Kong, S. X. [2 ]
Mernagh, P. [3 ]
Singh, R. [2 ]
Folkerts, K. [4 ]
Allen, S. [2 ]
Sullivan, S. [1 ]
机构：
[1] Curta Inc, Seattle, WA USA
[2] Bayer US LLC, Whippany, NJ USA
[3] Bayer AG, Berlin, BE, Germany
[4] Bayer AG, Berlin, Germany
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
CO41
引用
收藏
页码：S21 / S22
页数：2
相关论文
共 50 条
  • [21] A short and long-term outcomes of heart failure with midrange and preserved ejection fraction; developing countries perspective
    Leesutipornchai, T.
    Puwanant, S.
    Siwamogsatham, S.
    Aekarach, A.
    [J]. EUROPEAN HEART JOURNAL, 2022, 43
  • [22] The impact of specialty input on long-term outcomes in patients admitted for heart failure with preserved ejection fraction
    Badawy, L.
    Anyu, A. Ta
    Cannata, A. Antonio
    Scott, P.
    Piper, S.
    Bromage, D.
    Mcdonagh, T.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2022, 24 : 75 - 75
  • [23] Long-term outcomes in patients with critical limb ischemia and heart failure with preserved or reduced ejection fraction
    Khaira, Kavita B.
    Brinza, Ellen
    Singh, Gagan D.
    Amsterdam, Ezra A.
    Waldo, Stephen W.
    Tong, Kathleen
    Pandya, Kruti
    Laird, John R.
    Armstrong, Ehrin J.
    [J]. VASCULAR MEDICINE, 2017, 22 (04) : 307 - 315
  • [24] Poor Adherence to Medication is an Independent Risk Factor for Adverse Clinical Outcomes in Heart Failure with Reduced Ejection Fraction (HFrEF) but not Heart Failure with Preserved Ejection Fraction (HFpEF)
    Kato, Naoko
    Kinugawa, Koichiro
    Nakayama, Etsuko
    Tsuji, Takako
    Kumagai, Yumiko
    Miura, Chikako
    Nagayama, Masayoshi
    Sumiyoshi, Tetsuya
    Tomoike, Hitonobu
    Nagai, Ryozo
    [J]. CIRCULATION, 2012, 126 (21)
  • [25] Long-term Prognostic Value Of Heart Failure Survival Score In Heart Failure With Preserved Ejection Fraction
    Giverts, Ilya
    Poltavskaya, Maria
    Serova, Maria
    Gold, Fradah
    Da Andreev
    [J]. JOURNAL OF CARDIAC FAILURE, 2023, 29 (04) : 663 - 663
  • [26] Blood Hemoglobin is an Independent Predictor of Long-Term Clinical Outcomes in Heart Failure With Preserved Ejection Fraction With Chronic Kidney Disease
    Okuno, Keisuke
    Naito, Yoshiro
    Asakura, Masanori
    Sugahara, Masataka
    Ando, Tomotaka
    Nagai, Toshiyuki
    Saito, Yoshihiko
    Yoshikawa, Tsutomu
    Masuyama, Tohru
    Anzai, Toshihisa
    [J]. CIRCULATION, 2018, 138
  • [27] Impact of Anemia on Long-Term Clinical Outcomes is Different in Heart Failure With Preserved Ejection Fraction Patients With and Without Atrial Fibrillation
    Okuno, Keisuke
    Naito, Yoshiro
    Asakura, Masanori
    Sugahara, Masataka
    Ando, Tomotaka
    Nagai, Toshiyuki
    Saito, Yoshihiko
    Yoshikawa, Tsutomu
    Masuyama, Tohru
    Anzai, Toshihisa
    [J]. CIRCULATION, 2018, 138
  • [28] Is there a difference in precipitants between heart failure with preserved ejection fraction (HFPEF) and heart failure with reduced ejection fraction (HFREF)?
    Ali, S. M.
    Easton, K.
    Peck, K. Y.
    Hare, J.
    Kaye, D.
    Parikh, S.
    Hopper, I.
    [J]. AUSTRALASIAN JOURNAL ON AGEING, 2018, 37 : 37 - 38
  • [29] In the heart and beyond: Mitochondrial dysfunction in heart failure with preserved ejection fraction (HFpEF)
    Bhattarai, Nisha
    Scott, Iain
    [J]. CURRENT OPINION IN PHARMACOLOGY, 2024, 76
  • [30] Heart failure preserved ejection fraction (HFpEF): an integrated and strategic review
    Lekavich, Carolyn L.
    Barksdale, Debra J.
    Neelon, Virginia
    Wu, Jia-Rong
    [J]. HEART FAILURE REVIEWS, 2015, 20 (06) : 643 - 653
12345